-
Question: Cimzia ( an anti TNF alpha drug produced by UCB) targets and mutates TNF and the receptor cells of the B-cells therefore stopping inflammatory diseases such as rheumatoid arthritis. Surely mutating the receptors of the B-cells means that the body is poorly protected against disease. Would a drug which only mutated the TNF protein be just as effective without compromising the bodies' defence against disease?
Comments
iamripped commented on :
safe yeah